Your browser doesn't support javascript.
loading
Grabody B, an IGF1 receptor-based shuttle, mediates efficient delivery of biologics across the blood-brain barrier.
Shin, Jung-Won; An, Sungwon; Kim, Dongin; Kim, Hyunjoo; Ahn, Jinhyung; Eom, Jaehyun; You, Weon-Kyoo; Yun, Hyesu; Lee, Bora; Sung, Byungje; Jung, Jinwon; Kim, Sehyun; Son, Yonggyu; Sung, Eunsil; Lee, Hanbyul; Lee, Suyeon; Song, Daehae; Pak, Youngdon; Sandhu, Jagdeep K; Haqqani, Arsalan S; Stanimirovic, Danica B; Yoo, Jiseon; Kim, Donghwan; Maeng, Sungho; Lee, Jeonghun; Lee, Sang Hoon.
Afiliação
  • Shin JW; ABL Bio, Inc., Seongnam-si, South Korea.
  • An S; ABL Bio, Inc., Seongnam-si, South Korea.
  • Kim D; ABL Bio, Inc., Seongnam-si, South Korea.
  • Kim H; ABL Bio, Inc., Seongnam-si, South Korea.
  • Ahn J; ABL Bio, Inc., Seongnam-si, South Korea.
  • Eom J; ABL Bio, Inc., Seongnam-si, South Korea.
  • You WK; ABL Bio, Inc., Seongnam-si, South Korea.
  • Yun H; ABL Bio, Inc., Seongnam-si, South Korea.
  • Lee B; ABL Bio, Inc., Seongnam-si, South Korea.
  • Sung B; ABL Bio, Inc., Seongnam-si, South Korea.
  • Jung J; ABL Bio, Inc., Seongnam-si, South Korea.
  • Kim S; ABL Bio, Inc., Seongnam-si, South Korea.
  • Son Y; ABL Bio, Inc., Seongnam-si, South Korea.
  • Sung E; ABL Bio, Inc., Seongnam-si, South Korea.
  • Lee H; ABL Bio, Inc., Seongnam-si, South Korea.
  • Lee S; ABL Bio, Inc., Seongnam-si, South Korea.
  • Song D; ABL Bio, Inc., Seongnam-si, South Korea.
  • Pak Y; ABL Bio, Inc., Seongnam-si, South Korea.
  • Sandhu JK; National Research Council Canada, Ottawa, ON, Canada.
  • Haqqani AS; National Research Council Canada, Ottawa, ON, Canada.
  • Stanimirovic DB; National Research Council Canada, Ottawa, ON, Canada.
  • Yoo J; ABL Bio, Inc., Seongnam-si, South Korea.
  • Kim D; ABL Bio, Inc., Seongnam-si, South Korea.
  • Maeng S; Department of Comprehensive Health Science, Kyung Hee University, Yongin-si, South Korea.
  • Lee J; Department of Comprehensive Health Science, Kyung Hee University, Yongin-si, South Korea.
  • Lee SH; ABL Bio, Inc., Seongnam-si, South Korea.
Cell Rep Methods ; 2(11): 100338, 2022 11 21.
Article em En | MEDLINE | ID: mdl-36452865
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Barreira Hematoencefálica Tipo de estudo: Prognostic_studies Aspecto: Implementation_research Limite: Animals Idioma: En Revista: Cell Rep Methods Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Barreira Hematoencefálica Tipo de estudo: Prognostic_studies Aspecto: Implementation_research Limite: Animals Idioma: En Revista: Cell Rep Methods Ano de publicação: 2022 Tipo de documento: Article